INIS
patients
100%
control
85%
myeloid leukemia
83%
genes
71%
genotype
66%
cancer
57%
genetics
53%
populations
49%
receptors
46%
mice
40%
drugs
39%
breasts
39%
risks
34%
diseases
34%
leukemia
31%
metabolism
30%
values
29%
humans
28%
liver
23%
comparative evaluations
22%
regulations
22%
blood
21%
females
20%
dna
20%
schools
20%
tumors
19%
sudan
18%
reductases
18%
mutations
17%
males
17%
data
16%
carcinogenesis
16%
membranes
16%
tamoxifen
16%
prostate
16%
growth factors
16%
hemoglobin
16%
estrogens
15%
rats
13%
distribution
12%
rflps
12%
electrophoresis
12%
blood cells
12%
cellulose
12%
acetates
12%
enzymes
12%
cars
12%
dexamethasone
12%
carcinogens
12%
pcr
12%
Biochemistry, Genetics and Molecular Biology
Myeloid
83%
Genotyping
58%
Nested Gene
46%
Allele
24%
Haplotype
20%
Mutation
17%
N-Acetyltransferase 2
16%
CYP3A5
16%
Drug Metabolism
16%
Regulatory Mechanism
16%
Expression Analysis
16%
Pharmacogenetics
16%
Development
15%
Association
14%
Methylenetetrahydrofolate Reductase
12%
Electrophoresis
12%
Cellulose Acetate
12%
Sample
11%
Hemoglobin
11%
DNA
10%
Case-Control Study
10%
Age
10%
Polymerase Chain Reaction
9%
Rat
9%
Mutant
9%
Metabolic Pathway
9%
Gene Frequency
8%
Carcinogenesis
8%
Human
8%
Prevalence
8%
Gender
8%
CYP2D6
8%
CYP3A4
8%
Incidence
8%
Coronavirinae
8%
Cytochrome P450
7%
BRCA1
7%
Estrogen Receptor
7%
Mannose 6-Phosphate
6%
Insulin-Like Growth Factor 2 Receptor
6%
Mouse
6%
Lysozyme
6%
CYP3A
6%
Blood Cell Count
6%
Normal Human
5%
Cation Exchange
5%
High-Performance Liquid Chromatography
5%
Polymerase Chain Reaction
5%
Methylation
5%
(Methionine Synthase) Reductase
5%
Medicine and Dentistry
Breast Cancer
23%
Tamoxifen
16%
Acute Myeloid Leukemia
16%
Protein P53
13%
Omega-3 Fatty Acid
13%
Gene
12%
Diseases
12%
Patient
12%
Transforming Growth Factor Beta
9%
Carcinogenesis
9%
Girl
9%
Diethylstilbestrol
8%
Sickle-Cell Disease
8%
Hydroxyurea
8%
Case-Control Study
8%
Female
8%
BRCA1
7%
Age
7%
Breast Tissue
7%
Estrogen Receptor
7%
Prevalence
6%
Epigenetic Mechanism
6%
Malignant Neoplasm
6%
Neoplasm
5%
Signal Transduction
5%
Family History
5%
BRCA2
5%
Immunoglobulin Enhancer Binding Protein
5%
Supplementation
5%
Integrin
5%
Serositis
5%
Genetic Polymorphism
5%
Patient with Sickle Cell Disease
5%
Incidence
5%
Screening
5%
Woman
5%